Use of CT/CT angiography, often more readily available than MRI, after a transient ischemic attack or minor stroke predicts risk of recurrent stroke and clinical outcome.
Use of CT/CT angiography (CTA) as soon as possible in patients presenting with transient ischemic attacks (TIA) or minor stroke predicts risk of recurrent stroke and clinical outcome, according to a study published online in Stroke: Journal of the American Heart Association.
Although MRIs are frequently used for early assessment, CT scanners are usually more readily available to the emergency department, said the study authors. The median waiting time for diffusion-weighted MRI was 17.5 hours, but for CTA imaging, the wait was only 5.5 hours. In addition, CTA does not take much time, adding only five minutes to the standard CT brain scan.
It is estimated that there is a 10 percent risk of recurrent stroke within 90 days of a patient experiencing a TIA or minor stroke, with the majority recurrent strokes occurring within 48 hours of TIA or mild stroke onset. CTA, which uses contrast media to image the vasculature, can identify large artery disease, allowing physicians to determine risk. “A symptomatic intracranial or extracranial severe arterial stenosis or occlusion was predictive of recurrent stroke,” wrote the authors.
In the study, 491 patients with either TIA or minor stroke underwent CT/CTA within 24 hours of onset and most had subsequent MRI. Results showed there were 36 recurrent strokes, with a median time to the event of one day, and a positive CT/CTA scan was a predictor of recurrent stroke.
The authors concluded, “Adoption of CT/CTA into clinical practice for the assessment of patients with TIA and minor stroke identifies a high risk group suitable for aggressive acute stroke prevention treatment.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.